Rituxan in vivo purging of stem cells for autologous transplantation in chronic lymphocytic leukemia (CLL).

被引：0
|
作者：
Berkahn, LC
Simpson, DR
Raptis, A
Pavletic, S
Klingemann, HG
机构：
[1] Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA
[2] Univ Nebraska, Med Ctr, Lincoln, NE 68583 USA
[3] IDEC, San Diego, CA USA
[4] Genentech Inc, S San Francisco, CA 94080 USA
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
799
引用
收藏
页码：186A / 186A
页数：1
相关论文
共 50 条
  • [41] Effectiveness of rituximab for in vivo purging before harvest of peripheral stem cells in chronic lymphocytic leukaemia
    Shvidel, L
    Shtalrid, M
    Bassous, L
    Harpaz, N
    Berrebi, A
    BONE MARROW TRANSPLANTATION, 2004, 33 : S152 - S152
  • [42] Stem Cell Transplantation in Chronic Lymphocytic Leukemia
    Gribben, John G.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (01) : 53 - 58
  • [43] Improved survival with allogeneic and autologous stem cell transplantation for chronic lymphocytic leukemia (CLL): A case-matched analysis with conventional chemotherapy.
    Khouri, I
    Keating, M
    Lerner, S
    O'Brien, S
    Champlin, R
    BLOOD, 1998, 92 (10) : 287A - 287A
  • [44] Efficiency of in vivo purging with autologous stem cell transplantation and rituximab in B-CLL non-Hodgkin's lymphoma
    Tothova, E
    Stecova, N
    Kafkova, A
    Guman, T
    Fricova, M
    Svorcova, E
    BONE MARROW TRANSPLANTATION, 2003, 31 : S76 - S76
  • [45] Feasiblity of autologous stem cell transplantation (ASCT) in chronic lymphocytic leukemia (CLL) patients treated with sequential fludarabine and Campath-1H.
    Tedeschi, A
    Cairoli, R
    Montillo, M
    Marenco, P
    Grillo, G
    Rossi, V
    Cafro, AM
    Intropido, L
    Morra, E
    BLOOD, 2004, 104 (11) : 520A - 520A
  • [46] Autologous hematopoietic cell transplantation (AUTO-HCT) in chronic lymphocytic leukemia (CLL): Results of a systematic review
    Haifan-Dabaja, M. A.
    Kumar, A.
    Behera, M.
    Field, T.
    Ayala, E.
    Perez, L.
    Fernandez, H.
    Anasetti, C.
    Dillbegovic, B.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 37 - 38
  • [47] AUTOLOGOUS AND ALLOGENEIC MLR REACTIVITY IN PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL)
    KABELITZ, D
    ANDRIGHETTO, C
    SIMONSSON, B
    WIGZELL, H
    IMMUNOBIOLOGY, 1981, 159 (1-2) : 25 - 25
  • [48] Pathway inhibitors for bridging to allogeneic hematopoietic stem cell transplantation (HSCT) for chronic lymphocytic leukemia (CLL)
    Hahn, M.
    Dietrich, S.
    Hain, S-A
    Hegenbart, U.
    Rieger, M.
    Scheuer, B.
    Ho, A. D.
    Dreger, P.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 13 - 14
  • [49] Hematopoetic stem cell transplantation (SCT) in chronic lymphocytic leukemia (CLL): A single institution experience.
    Esteve, J
    Villamor, N
    Bosch, F
    Lopez-Guillermo, A
    Rovira, M
    Urbano-Ispizua, A
    Colomer, D
    Carreras, E
    Montserrat, E
    BONE MARROW TRANSPLANTATION, 1998, 21 : S77 - S77
  • [50] Autologous stem cell transplantation for acute lymphocytic leukemia in adults
    Martin, TG
    Linker, CA
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2001, 15 (01) : 121 - +
12345